S 1348
115th Congress
Senate
Health
Civil actions and liability
Corporate finance and management
Government information and archives
Inflation and prices
Marketing and advertising
Prescription drugs
Research and development
Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jun 13, 2017
Read twice and referred to the Committee on Finance.
Jun 13, 2017
Introduced in Senate
Plain-English summary
Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017
This bill amends title XI (General Provisions) of the Social Security Act to require manufacturers of drugs with specified percentage increases in their wholesale costs to submit to the Centers for Medicare & Medicaid Services (CMS) written justification for certain increases in drug prices. The CMS shall publish each submission, together with an easily understandable summary, on its website. Certain proprietary information may be excluded from publication, as specified by the bill.
A manufacturer that does not comply with the bill's requirements shall be subject to civil monetary penalties.
What's happening now
Read twice and referred to the Committee on Finance.
Committees of jurisdiction
1